readthroughSign in
CompanyPRQRNasdaqLeiden

ProQR Therapeutics N.V.

ProQR Therapeutics develops RNA therapies using its Axiomer platform technology, which leverages ADAR-mediated editing to correct single nucleotide mutations in RNA.

6-KNov 12Latest SEC filing
Nov 12Latest story